Site Search
Search Results
Data Collection and Cancer Health Equity
Health equity in cancer care means that everyone has a fair and just opportunity to prevent, find, treat and survive cancer regardless of race, ethnicity, gender, age, sexual orientation, socioeconomic status or zip code. Addressing health equity in cancer starts with timely, complete, and accurate data on populations and demographics that are facing cancer disparities. Data Collection and Cancer Health Equity ...
Cancer Research and Disparities: Understanding and Addressing the Issues
The COVID-19 pandemic has made clear the significant disparities that exist in our health care system and the need to address their root causes, including in cancer care. Ensuring all individuals – regardless of age, race, ethnicity, socioeconomic status, education, sexual orientation, insurance status, or ...
Community Letter Urging Congress to Enact Diagnostic Oversight Reform
Leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers called on Senate and House leaders to ... innovative diagnostics and clinical laboratory tests to market. In a letter to the Chairmen and Ranking members of the Senate Committee on Health, Education, Labor & Pensions (HELP) and House Energy and Commerce Committee, more than 80 organizations urged Congress to prioritize ...
Overwhelming Majority of Cancer Patients and Survivors Support Broad Community Immunization and Oppose Limiting Access to Vaccines
... Key Findings Community immunization is very important to cancer patients and survivors; 88% say it is important for those they encounter in a health care facility to be up to date on vaccinations, and 83% say immunization is important for those in their broader community. 76% oppose states ... those around them are up to date on recommended vaccinations. Eighty-eight percent agree that it is important that those they encounter in their health care facilities are vaccinated and 73% say it is very important. Among those with school-aged children, 85% say it is important that those ...
Improving Access to Biomarker Testing
... from patients to identify and evaluate cancer biomarkers. Testing patients for specific biomarkers is integral to precision medicine in cancer care, but despite evidence pointing to the clinical benefits associated with biomarker testing, routine clinical use does not always follow, and ... insurance would not cover it or their out-of-pocket costs would be too high. A new report by ACS CAN and LUNGevity Foundation found while health insurance coverage for biomarker testing has improved since the organizations’ last report in 2018, coverage is still failing to keep up ... a combination of factors, as highlighted in the ACS CAN report Improving Access to Biomarker Testing - Advancing Precision Medicine in Cancer Care which explores the current landscape of cancer biomarker testing, sheds light on the nature of challenges limiting adoption of appropriate ...
Survivor Views on Artificial Intelligence and FDA Medical Product Reviews
... of cancer patients and survivors agree that the industries making FDA-regulated products should provide some of the cost of FDA’s public health oversight Cancer patients and survivors mirror the American public in their hesitancy to embrace AI, with 51% reporting they are more ... excited about the technology compared to only 5% who are more excited than concerned. Respondents have mixed expectations of the impact of AI on health care, with a plurality (39%) predicting the impact over the next 20 years to be equally positive and negative. Cancer patients and survivors offer ...